[96a5a0]: / output / allTrials / identified / NCT05979220_identified.json

Download this file

365 lines (365 with data), 15.1 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
{
"info": {
"nct_id": "NCT05979220",
"official_title": "A Multicenter, Single Arm, Prospective Phase II Clinical Study of Dalpiciclib Combined With Letrozole in the Maintenance Treatment of HR Positive and HER2 Negative Metastatic Breast Cancer After First-line Chemotherapy",
"inclusion_criteria": "1. Has the pathologically-confirmed diagnosis of locally recurrent or metastatic, hormone-receptor positive, HER2 negative Breast Cancer.\n2. Age: 18 - 75 years old\n3. Eastern Cooperative Oncology Group performance status (ECOG PS)=0~1\n4. Functions of liver and kidney is normal\n5. Agreed to take contraceptive measures during treatment\nHealthy volunteers allowed\nMust be FEMALE\nMust have minimum age of 18 Years\nMust have maximum age of 75 Years",
"exclusion_criteria": "1. Confirmed diagnosis of HER2 positive disease.\n2. Central nervous system metastasis\n3. Patients who received prior treatment with any CDK4/6 inhibitor.\n4. Clinically significant cardiovascular and cerebrovascular diseases,including but not limited to severe acute myocardial infarction within 6 months before enrollment, unstable or severe angina, Congestive heart failure (New York heart association (NYHA) class > 2), or ventricular arrhythmia which need medical intervention;\n5. Researchers believe that is not suitable for the study",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "1. Has the pathologically-confirmed diagnosis of locally recurrent or metastatic, hormone-receptor positive, HER2 negative Breast Cancer.",
"criterions": [
{
"exact_snippets": "pathologically-confirmed diagnosis",
"criterion": "diagnosis confirmation",
"requirements": [
{
"requirement_type": "confirmation",
"expected_value": true
}
]
},
{
"exact_snippets": "locally recurrent or metastatic",
"criterion": "cancer stage",
"requirements": [
{
"requirement_type": "stage",
"expected_value": [
"locally recurrent",
"metastatic"
]
}
]
},
{
"exact_snippets": "hormone-receptor positive",
"criterion": "hormone receptor status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "positive"
}
]
},
{
"exact_snippets": "HER2 negative",
"criterion": "HER2 status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "negative"
}
]
},
{
"exact_snippets": "Breast Cancer",
"criterion": "cancer type",
"requirements": [
{
"requirement_type": "type",
"expected_value": "Breast Cancer"
}
]
}
]
},
{
"line": "2. Age: 18 - 75 years old",
"criterions": [
{
"exact_snippets": "Age: 18 - 75 years old",
"criterion": "age",
"requirements": [
{
"requirement_type": "range",
"expected_value": {
"comparisons": [
{
"operator": ">=",
"value": 18,
"unit": "years"
},
{
"operator": "<=",
"value": 75,
"unit": "years"
}
]
}
}
]
}
]
},
{
"line": "3. Eastern Cooperative Oncology Group performance status (ECOG PS)=0~1",
"criterions": [
{
"exact_snippets": "Eastern Cooperative Oncology Group performance status (ECOG PS)=0~1",
"criterion": "Eastern Cooperative Oncology Group performance status (ECOG PS)",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"comparisons": [
{
"operator": "=",
"value": 0,
"unit": "N/A"
},
{
"operator": "=",
"value": 1,
"unit": "N/A"
}
]
}
}
]
}
]
},
{
"line": "4. Functions of liver and kidney is normal",
"criterions": [
{
"exact_snippets": "Functions of liver ... is normal",
"criterion": "liver function",
"requirements": [
{
"requirement_type": "status",
"expected_value": "normal"
}
]
},
{
"exact_snippets": "Functions of ... kidney is normal",
"criterion": "kidney function",
"requirements": [
{
"requirement_type": "status",
"expected_value": "normal"
}
]
}
]
},
{
"line": "5. Agreed to take contraceptive measures during treatment",
"criterions": [
{
"exact_snippets": "Agreed to take contraceptive measures during treatment",
"criterion": "contraceptive measures",
"requirements": [
{
"requirement_type": "agreement",
"expected_value": true
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must be FEMALE",
"criterions": [
{
"exact_snippets": "Must be FEMALE",
"criterion": "gender",
"requirements": [
{
"requirement_type": "expected_value",
"expected_value": "female"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
},
{
"line": "Must have maximum age of 75 Years",
"criterions": [
{
"exact_snippets": "maximum age of 75 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "maximum",
"expected_value": {
"operator": "<=",
"value": 75,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "1. Confirmed diagnosis of HER2 positive disease.",
"criterions": [
{
"exact_snippets": "Confirmed diagnosis of HER2 positive disease",
"criterion": "HER2 positive disease",
"requirements": [
{
"requirement_type": "diagnosis",
"expected_value": true
}
]
}
]
},
{
"line": "2. Central nervous system metastasis",
"criterions": [
{
"exact_snippets": "Central nervous system metastasis",
"criterion": "central nervous system metastasis",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "3. Patients who received prior treatment with any CDK4/6 inhibitor.",
"criterions": [
{
"exact_snippets": "Patients who received prior treatment with any CDK4/6 inhibitor",
"criterion": "prior treatment with CDK4/6 inhibitor",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "4. Clinically significant cardiovascular and cerebrovascular diseases,including but not limited to severe acute myocardial infarction within 6 months before enrollment, unstable or severe angina, Congestive heart failure (New York heart association (NYHA) class > 2), or ventricular arrhythmia which need medical intervention;",
"criterions": [
{
"exact_snippets": "Clinically significant cardiovascular and cerebrovascular diseases",
"criterion": "cardiovascular and cerebrovascular diseases",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "clinically significant"
}
]
},
{
"exact_snippets": "severe acute myocardial infarction within 6 months before enrollment",
"criterion": "acute myocardial infarction",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "severe"
},
{
"requirement_type": "time frame",
"expected_value": "within 6 months before enrollment"
}
]
},
{
"exact_snippets": "unstable or severe angina",
"criterion": "angina",
"requirements": [
{
"requirement_type": "severity",
"expected_value": [
"unstable",
"severe"
]
}
]
},
{
"exact_snippets": "Congestive heart failure (New York heart association (NYHA) class > 2)",
"criterion": "congestive heart failure",
"requirements": [
{
"requirement_type": "classification",
"expected_value": {
"operator": ">",
"value": 2,
"unit": "NYHA class"
}
}
]
},
{
"exact_snippets": "ventricular arrhythmia which need medical intervention",
"criterion": "ventricular arrhythmia",
"requirements": [
{
"requirement_type": "treatment necessity",
"expected_value": true
}
]
}
]
},
{
"line": "5. Researchers believe that is not suitable for the study",
"criterions": [
{
"exact_snippets": "Researchers believe that is not suitable for the study",
"criterion": "suitability for the study",
"requirements": [
{
"requirement_type": "suitability",
"expected_value": false
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}